Bridge, J., Hunter, B.M., Albers, E., et al. The International Journal of Drug Policy (September 2015), doi: http://dx.doi.org/10.1016/j.drugpo.2015.08.001.
The authors of this study reviewed grant budget data for the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) between 2002 and 2014 to develop a comprehensive dataset on the Global Fund's investments in harm reduction for people who inject drugs (PWID).They identified 151 grants for 58 countries and one regional proposal, with a total budget of US$620 million. Of the 58 countries, 21 were from Eastern Europe and Central Asia, 17 from Asia, 10 from the Middle East and North Africa, 7 from sub-Saharan Africa, and 3 from Latin America and the Caribbean; the regional grant was for the Middle East and North Africa Harm Reduction Network. Global Fund investments targeting PWID mainly focused on the nine interventions comprising the United Nations’ ‘‘comprehensive package’’ for PWID, with 15 percent allocated overall for program management and grant overheads. The budget analysis also identified US$7.7 million for interventions and activities in compulsory drug detention centers in Asia. The authors recommended using this study as a baseline, and undertaking further analysis to understand the impact of the new funding model on harm reduction allocations as new grant agreements are signed. The analysis should also inform the development of the Global Fund’s new strategy for 2017–2021.